These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33479741)

  • 1. Targeting the Opioid Receptors: A Promising Therapeutic Avenue for Treatment in "Heavy Drinking Smokers".
    Domi A; Barbier E; Adermark L; Domi E
    Alcohol Alcohol; 2021 Feb; 56(2):127-138. PubMed ID: 33479741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic management of co-morbid alcohol and opioid use.
    Hood LE; Leyrer-Jackson JM; Olive MF
    Expert Opin Pharmacother; 2020 May; 21(7):823-839. PubMed ID: 32103695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco and alcohol use disorders: Evaluating multimorbidity.
    MacLean RR; Sofuoglu M; Rosenheck R
    Addict Behav; 2018 Mar; 78():59-66. PubMed ID: 29127785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study.
    Di Nicola M; De Filippis S; Martinotti G; De Risio L; Pettorruso M; De Persis S; Maremmani AGI; Maremmani I; di Giannantonio M; Janiri L
    Adv Ther; 2017 Jul; 34(7):1636-1649. PubMed ID: 28540656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossover associations of alcohol and smoking, craving and biochemically verified alcohol and nicotine use in heavy drinking smokers.
    Smith CL; Jenkins G; Burduli E; Tham P; Miguel A; Roll J; Mcpherson S
    Behav Pharmacol; 2020 Oct; 31(7):702-705. PubMed ID: 32516270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking kills (alcoholics)! shouldn't we do something about it?
    Littleton J; Barron S; Prendergast M; Nixon SJ
    Alcohol Alcohol; 2007; 42(3):167-73. PubMed ID: 17526626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 years and older: results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions.
    Lin JC; Karno MP; Grella CE; Ray LA; Liao DH; Moore AA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1356-63. PubMed ID: 24021218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.
    Rutten K; Schröder W; Christoph T; Koch T; Tzschentke TM
    Eur J Pharmacol; 2018 May; 827():41-48. PubMed ID: 29524385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the opioid system in alcohol dependence.
    Nutt DJ
    J Psychopharmacol; 2014 Jan; 28(1):8-22. PubMed ID: 24048097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of Alcohol, Tobacco, and Drug Use Disorders Among Sexual Minority Individuals and Their "Not Sure" Counterparts.
    Boyd CJ; Veliz PT; Stephenson R; Hughes TL; McCabe SE
    LGBT Health; 2019 Jan; 6(1):15-22. PubMed ID: 30638419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and factors associated with potential substance use disorders among police officers in urban Tanzania: a cross-sectional study.
    Ndumwa HP; Njiro BJ; Francis JM; Kawala T; Msenga CJ; Matola E; Mhonda J; Corbin H; Ubuguyu O; Likindikoki S
    BMC Psychiatry; 2023 Mar; 23(1):175. PubMed ID: 36927411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous opioid systems and alcohol addiction.
    Herz A
    Psychopharmacology (Berl); 1997 Jan; 129(2):99-111. PubMed ID: 9040115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats.
    Nielsen CK; Simms JA; Pierson HB; Li R; Saini SK; Ananthan S; Bartlett SE
    Biol Psychiatry; 2008 Dec; 64(11):974-81. PubMed ID: 18774553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of nalmefene in patients with comorbid borderline personality disorder and alcohol use disorder: a preliminary report.
    Martín-Blanco A; Patrizi B; Soler J; Gasol X; Elices M; Gasol M; Carmona C; Pascual JC
    Int Clin Psychopharmacol; 2017 Jul; 32(4):231-234. PubMed ID: 28181957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder: Targeting the Opioidergic, Noradrenergic, Serotonergic, and GABAergic/Glutamatergic Systems.
    Verplaetse TL; McKee SA; Petrakis IL
    Alcohol Res; 2018; 39(2):193-205. PubMed ID: 31198658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting opioid and neurokinin-1 receptors to treat alcoholism.
    Rodriguez FD; Coveñas R
    Curr Med Chem; 2011; 18(28):4321-34. PubMed ID: 21861818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
    Soyka M; Rösner S
    Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.